Delgado Introduces Legislation to Stop Political Contributions from Opioid Manufacturers
WASHINGTON, DC—Today, Representative Antonio Delgado (NY-19) along with Rep. Max Rose (NY-11) introduced legislation to halt political contributions from opioid manufacturers. The Save Lives Act would prohibit donations from corporate political action committees (PACs) of pharmaceutical companies that manufacture opioids.
“Addressing the opioid crisis must also include rooting out the corrupting influences that perpetuate it. The opioid crisis is deeply prevalent in New York, especially in our rural communities, and yet pharmaceutical companies and special interests continue to have free rein to advance their agenda by lining the pockets of lawmakers in Washington,” said Rep. Delgado. “The Save Lives Act will take important steps to limit the influence of opioid manufacturers and make sure our Representatives work for the people they serve—not special interests.”
Rep. Rose said, “After poisoning our children and killing our loved ones, opioid manufacturers should not be able to flood Washington with corporate PAC money to buy protection from prosecution. We must end the corruption and work to bring justice to those impacted by their reckless and dangerous actions.”
“Eliminating Big Pharma’s stranglehold over Congress is a powerful step in addressing the opioid crisis,” said End Citizens United Action Fund President Tiffany Muller. “For too long, Big Pharma and its unlimited money has prevented action and progress on issues that affect the lives of the American people. Rep. Delgado and Rose’s bill is common-sense legislation that will prevent the companies perpetuating the opioid epidemic from buying off politicians. End Citizens United thanks Reps. Delgado and Rose for their continued leadership and commitment to rooting out Big Pharma’s undue influence over our politics.”
The Save Lives Act would prohibit drug manufacturers’ corporate PACs from supporting federal candidates. Earlier this week, Rep. Delgado helped to introduce legislation banning all corporate PACs, limiting the influence of corporate special interests in politics. This Spring, Rep. Delgado introduced bipartisan legislation, H.R. 2482: the Mainstreaming Addiction Treatment Act, that would end an outdated redundancy in federal law that restricts health providers from prescribing buprenorphine, a proven treatment that has helped countless Americans suffering with a substance use disorder.